Elanco Animal Health (ELAN) Non-Current Deferred Tax Liability (2017 - 2026)

Elanco Animal Health (ELAN) reported Non-Current Deferred Tax Liability of $366.0 million for Q1 2026, down 23.91% on a YoY basis from $481.0 million in Q1 2025, and down 4.19% sequentially from $382.0 million in Q4 2025.

Elanco Animal Health (ELAN) Non-Current Deferred Tax Liability (2017 - 2026) Analysis & Trends

Elanco Animal Health (ELAN) has 10 years of Non-Current Deferred Tax Liability data on file, last reported at $366.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Deferred Tax Liability fell 23.91% year-over-year to $366.0 million; the trailing twelve-month figure through Mar 2026 stood at $366.0 million (down 23.91% YoY), and the FY2025 full-year result was $382.0 million, down 14.92% from the prior year.
  • Non-Current Deferred Tax Liability retreated to $366.0 million in Q1 2026, from $382.0 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $1.1 billion in Q4 2022 to a low of $366.0 million in Q1 2026.
  • A 5-year average of $578.4 million and a median of $539.0 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
  • Across the five-year window, Non-Current Deferred Tax Liability jumped 40.13% in 2022 and tumbled 47.11% in 2023, its largest moves.
  • Tracing ELAN's Non-Current Deferred Tax Liability over 5 years: stood at $1.1 billion in 2022, then tumbled by 47.11% to $567.0 million in 2023, then decreased by 20.81% to $449.0 million in 2024, then retreated by 14.92% to $382.0 million in 2025, then fell by 4.19% to $366.0 million in 2026.
  • Business Quant data shows ELAN's Non-Current Deferred Tax Liability at $366.0 million in Q1 2026, $382.0 million in Q4 2025, and $478.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 366.00 Mn
Mar 31, 2026 366.00 Mn
Dec 31, 2025 382.00 Mn
Dec 31, 2025 382.00 Mn
Sep 30, 2025 478.00 Mn
Sep 30, 2025 478.00 Mn
Jun 30, 2025 496.00 Mn
Jun 30, 2025 496.00 Mn
Mar 31, 2025 481.00 Mn
Mar 31, 2025 481.00 Mn
Dec 31, 2024 449.00 Mn
Dec 31, 2024 449.00 Mn
Sep 30, 2024 539.00 Mn
Sep 30, 2024 539.00 Mn
Jun 30, 2024 524.00 Mn
Jun 30, 2024 524.00 Mn
Mar 31, 2024 530.00 Mn
Mar 31, 2024 530.00 Mn
Dec 31, 2023 567.00 Mn
Dec 31, 2023 567.00 Mn